Meeting
2020 ASCO Virtual Scientific Program
Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice using a hybrid study approach.
Authors
Jennifer Leigh Lund
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
Jennifer Leigh Lund , Michael Webster-Clark , Alexander P Keil , Daniel Westreich , Til Sturmer , Hanna Kelly Sanoff
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7067)
DOI
10.1200/JCO.2020.38.15_suppl.7067
Abstract #
7067
Poster Bd #
339
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.
First Author: Daniel Walden
Poster
2021 ASCO Quality Care Symposium
Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer.
First Author: Jennifer Leigh Lund
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2018 ASCO Annual Meeting
Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration.
First Author: Anthony Frank Shields